{
  "timestamp": "2026-01-22T23:31:06.720178",
  "total_validated": 54,
  "validation_results": {
    "FDA_approved_standard": 13,
    "clinical_trial_offlabel": 8,
    "research_support": 8,
    "weak_historical": 5,
    "false_positives": 15,
    "uncertain": 5
  },
  "key_metrics": {
    "biologically_plausible_rate": "72.2%",
    "false_positive_rate": "27.8%",
    "biologic_false_positive_rate": "54%"
  },
  "critical_findings": [
    {
      "finding": "Dantrolene \u2192 Heart Failure RCT validated",
      "significance": "P=0.034, 66% reduction in VT inducibility",
      "confidence": "VERY_HIGH"
    },
    {
      "finding": "Systematic bias in biologic predictions",
      "significance": "Model predicts ANY -mab for autoimmune without target understanding",
      "confidence": "HIGH"
    },
    {
      "finding": "Small molecules have 74% precision",
      "significance": "Better than biologics for most diseases",
      "confidence": "MEDIUM"
    }
  ],
  "filter_exclusions": {
    "harmful_predictions_caught": 7,
    "categories": [
      "Diagnostic agents (imaging not treatment)",
      "TCAs for hypertension (cause HTN)",
      "Sympathomimetics for diabetes (raise glucose)",
      "Alpha blockers for heart failure (ALLHAT: 2x risk)",
      "Tumor-promoting hormones for cancer",
      "Cardiac stress agents for hypertension",
      "Chemotherapy for metabolic diseases"
    ]
  },
  "biologic_filter_results": {
    "ms_predictions_tested": 13,
    "passed": 6,
    "failed": 7,
    "pass_rate": "46%",
    "fail_examples": [
      "Volociximab (anti-\u03b15\u03b21 for cancer)",
      "Trastuzumab (anti-HER2 for cancer)",
      "Romosozumab (anti-sclerostin for bone)",
      "Eptinezumab (anti-CGRP for migraine)"
    ]
  },
  "recommendations": {
    "share_with_every_cure": [
      "Dantrolene \u2192 Heart failure (RCT validated)",
      "Small molecule predictions passing confidence filter",
      "Predictions for well-understood disease mechanisms"
    ],
    "do_not_share": [
      "Biologic predictions without target validation",
      "Any prediction flagged by confidence filter",
      "Predictions for disease categories with <30% R@30"
    ],
    "requires_manual_review": [
      "Novel biologics with compatible targets but no clinical data",
      "Cytokine-targeting antibodies for non-studied autoimmune conditions"
    ]
  }
}